Pdt Partners, LLC Gilead Sciences, Inc. Transaction History

Pdt Partners, LLC

$1.02 Billion
Q3 2024

A detailed history of Pdt Partners, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 21,107 shares of GILD stock, worth $1.93 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

21,107

Holding current value

$1.93 Million

% of portfolio

0.17%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$66.59 - $83.99 $1.41 Million - $1.77 Million	21,107 New	21,107 $1.77 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $444,609 - $506,548	5,751 Added 166.74%	9,200 $763,000
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $214,941 - $308,582	3,449 New	3,449 $296,000
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $444,444 - $500,577	-7,700 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $445,984 - $558,866	7,700 New	7,700 $458,000
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $421,719 - $478,660	-6,500 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $4.42 Million - $4.77 Million	-65,300 Reduced 90.95%	6,500 $454,000
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $95,205 - $104,024	1,500 Added 2.13%	71,800 $4.94 Million
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $268,980 - $306,906	-4,483 Reduced 5.99%	70,300 $4.54 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $1.72 Million - $1.96 Million	-30,317 Reduced 28.85%	74,783 $4.36 Million
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $6.53 Million - $8.21 Million	105,100 New	105,100 $6.64 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $9.35 Million - $10.9 Million	-129,300 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $8.1 Million - $10.4 Million	129,300 New	129,300 $9.67 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $22.3 Million - $25 Million	-360,740 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $4.3 Million - $4.81 Million	68,691 Added 23.52%	360,740 $23.5 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $2.16 Million - $2.81 Million	35,631 Added 13.9%	292,049 $18.3 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $1,283 - $1,420	18 Added 0.01%	256,418 $19.8 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $2.06 Million - $2.41 Million	31,800 Added 14.16%	256,400 $18.2 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $1.7 Million - $2.08 Million	-23,400 Reduced 9.44%	224,600 $16.9 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $6.19 Million - $7.26 Million	86,940 Added 53.98%	248,000 $17.8 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $11.6 Million - $13.8 Million	161,060	161,060 $13 Million

Others Institutions Holding GILD

# of Institutions

1,940

Shares Held

989M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $115B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account